MetaCap

Autolus Therapeutics Statistics

NASDAQ: AUTLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.9073-0.0723 (-7.38%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Autolus Therapeutics by the numbers

Autolus Therapeutics has a market capitalization of $241.7 million based on 266.34M shares outstanding. With trailing EPS of $-0.96, Autolus Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 43.2% below its 50-day average and 45.0% below its 200-day average.

Average daily trading volume is 2.07M shares, or about $1.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

AUTL valuation vs. peer median

AUTL compared with the median of 8 peer companies
MetricAUTLPeer medianDifference
Market cap$241.65M$249.09M-3%
Avg. volume2.07M1.44M+44%

Peer median across 8 companies: PLX, LXEO, EDIT, SABS, SCTX, EIKN, OCGN, ALLO.

Valuation

Market cap
$241.65M
Price / sales (latest FY)
3.21
EPS (TTM)
$-0.96

Price and trading

Previous close
0.9796
Open
0.9641
Day range
0.8963 – 0.9797
52-week range
0.896 – 2.58
52-week change
-26.24%
Beta
—
Volume
3.90M

Dividends and events

Annual dividend
None
Next earnings date
Nov 10, 2026

Additional statistics

Market Cap
241.65M
Forward Pe
-1.60
Eps
-0.96
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
2.58
Week52 Low
0.90
Avg Volume
2.07M
Shares Outstanding
266.34M
Ma50
1.60
Ma200
1.65
Earnings Date
Nov 10, 2026
Pct From52w High
-64.83%
Pct From52w Low
1.26%

Related